In the News

1853 News Items found
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Man in surgical scrubs looks at reader
Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
Announcement
“We could not be more proud of this deserving group of the outstanding GSK students who have been recognized with fellowship support this academic year,” says GSK Dean Michael Overholtzer.
Shari Goldfarb, MD
In recognition of Breast Cancer Awareness Month, MSK shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers.
Charles Rudin and Dana Pe'er
Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.
Cesar Figueroa Ortiz posing for a photo with his parents
Home at Last: Cesar Figueroa Ortiz
Meet Cesar Figueroa Ortiz, who says, “The mission of MSK really resonated with me, all the employees seemed very happy, and the patients said great things about their care.”